Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. | 221,764 | reported | 15 Aug 2025 | tx 15+559,178−51,238 |
| MetaVia Inc. | 151,264 | reported | 24 Jul 2019 | tx 10+237,904−75,080 |
| ACORN ENERGY, INC. | 57,663 | reported | 23 Sept 2014 | tx 29+370,221 |
| EXICURE, INC. | 50,000 | reported | 02 Jun 2021 | tx 2+150,000 |
| STRATIVATION, INC. | 20,000 | reported | 01 Nov 2016 | tx 6+4,268,200 |
| ICAD INC | 0 | reported | 17 Jul 2025 | tx 85+682,777−2,235,714 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Aug 2025 | PURCHASE | Arcturus Therapeutics Holdings Inc. | 1,238 | 16.56 USD | first after silence |
| 17 Jul 2025 | OTHER | ICAD INC | 1,198,382 | — | |
| 17 Jul 2025 | OTHER | ICAD INC | 30,000 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 27,586 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 22,259 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 30,265 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 6,219 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 6,517 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 9,321 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 20,000 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 4,002 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 2,672 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 30,000 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 30,000 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 30,000 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 28,774 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 12,954 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 34,706 | — | deriv |
| 17 Jul 2025 | OTHER | ICAD INC | 30,000 | — | deriv |
| 03 Jan 2025 | GRANT_AWARD | ICAD INC | 30,000 | 0.00 USD | deriv |
| 16 Dec 2024 | GRANT_AWARD | Arcturus Therapeutics Holdings Inc. | 60,000 | 0.00 USD | deriv |
| 15 Aug 2024 | GRANT_AWARD | ICAD INC | 27,586 | 0.00 USD | deriv |
| 12 Jun 2024 | SALE | Arcturus Therapeutics Holdings Inc. | 50,000 | 32.03 USD | anomaly |
| 01 Apr 2024 | GRANT_AWARD | ICAD INC | 25,259 | 0.00 USD | deriv |
| 12 Jan 2024 | GRANT_AWARD | ICAD INC | 30,265 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 15 Aug 2025.